ELITechGroup achieves a new CE-IVDR Certification

  • ELITechGroup continues to expand its portfolio of IVDR-certified PCR assays to support European diagnostic laboratories
  • The newly obtained IVDR certificate will expedite the transition to IVDR for quantitative Class C infectious diseases assays
  • The company is fully committed to delivering its entire portfolio of nearly 60 molecular assays as IVDR compliant by 2026

Turin, Italy – May 29, 2024 – ELITechGroup is pleased to announce that they have obtained the IVDR certification for four new products including the brand new CMV RNA ELITe MGB Kit.
With the acquisition of this certification, ELITechGroup continues accelerating IVDR transition for the class C products for infectious diseases. This class includes all quantitative tests for infectious diseases follow up in transplant patients, such as the ELITe MGB CMV monitoring assay.

This significant milestone underscores ELITechGroup’s commitment to delivering high-quality and reliable diagnostic solutions to healthcare professionals worldwide. This achievement not only validates the rigorous standards the company adheres to in its product development but also reinforces its dedication to improving patient care through advanced diagnostic technologies.

ELITechGroup continues to lead the way in the development and commercialization of innovative diagnostic solutions, ensuring compliance with the highest regulatory standards.

About ELITechGroup 

ELITechGroup, part of Bruker Corp.,is an integrated in-vitro diagnostics company that serves hospitals and diagnostic laboratories in more than 100 countries. The company develops, manufactures, and markets a wide range of diagnostic products and solutions – instruments, reagents, and software.

ELITech Molecular Diagnostics (MDx) serves the needs of clinical and research laboratories by offering a wide range of molecular diagnostic products, including nearly 60 CE-IVD assays and instruments as well as software applications.

Latest news


ELITechGroup Announces Regulatory Approval of its Blood Borne Virus Panel in Japan

ELITechGroup’s blood-borne virus (BBV) panel received approval from Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) The ELITe BBV panel was launched in 2022 and comprises three quantitative IVD assays targeting Human Immunodeficiency virus-1 (HIV-1), Human Hepatitis B Virus (HBV), and Human Hepatitis C Virus (HCV) Turin, June 13, 2024: ELITechGroup…

ELITechGroup Launches Second IVDR Certified Gastrointestinal Infection Assay: GI Parasitic PLUS ELITe MGB® Kit 

ELITechGroup launches their second kit of the Gastrointestinal infection assay panel targeting parasitic pathogens.  The ELITe MGB Gastrointestinal assays are IVDR-certified in combination with InGenius and BeGenius, fully automated samples-to-results instruments.  The company will shortly launch two more gastrointestinal assay infection panels targeting viral pathogens and Norovirus.   ELITechGroup announces the…

Let us help you

For general inquiries, please use the links to the right. The Contact link leads to a brief online form, and the Support link offers general phone and email information. Someone will be in touch with you soon.